-
About UsBeijing Northland Biotechnology Co., Ltd. is an innovative biopharmaceutical company specializing in the research, development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs. -
R&D and ProductsPrimarily dedicated to the research, development, and industrialization of novel bioengineered drugs in areas such as cardiovascular diseases, metabolic disorders, rare diseases, and ophthalmic diseases. -
Investor RelationsGuided by the principle of “Creating Value, Serving Health,” the company is committed to becoming an innovative biopharmaceutical enterprise, contributing to the advancement of China’s pharmaceutical industry and the well-being of humanity.
2020
August 12: The hydrochloride olopatadine eye drops of our subsidiary, Huonland, have obtained the “Drug Registration Certificate.”
August 28: The investigator meeting for the Phase IIa study of NL005 was held.
November 23: NORTHLAND Holds an Online Roadshow
November 24: NORTHLAND Advances to the Select Tier of the New Third Board
December 24: NORTHLAND was awarded three honors by Wabai.com: "2020 Outstanding Chairman of the New Third Board," "2020 Leading Enterprise in the Medical and Healthcare Industry," and "2020 Secretary of the Board Contribution Award."
Share to:
Friendly Links: Baidu | NORTHLAND
Contact Information
Address: Room A406, Zhongguancun Biomedical Park, No. 5 Kaituo Road, Shangdi, Haidian District, Beijing
Follow Us
Northland is an innovative biopharmaceutical company specializing in the R&D, manufacturing and sales of gene therapy drugs, recombinant protein drugs and ophthalmic medications.
Web site
NL-BIO
NL003
NL005